Display options
Cite
Donninger H, Hobbing K, Schmidt ML, et al. A porcine model system of BRCA1 driven breast cancer. Front Genet. 2015;6:269doi: 10.3389/fgene.2015.00269.
Donninger, H., Hobbing, K., Schmidt, M. L., Walters, E., Rund, L., Schook, L., & Clark, G. J. (2015). A porcine model system of BRCA1 driven breast cancer. Frontiers in genetics, 6269. https://doi.org/10.3389/fgene.2015.00269
Donninger, Howard, et al. "A porcine model system of BRCA1 driven breast cancer." Frontiers in genetics vol. 6 (2015): 269. doi: https://doi.org/10.3389/fgene.2015.00269
Donninger H, Hobbing K, Schmidt ML, Walters E, Rund L, Schook L, Clark GJ. A porcine model system of BRCA1 driven breast cancer. Front Genet. 2015 Aug 25;6:269. doi: 10.3389/fgene.2015.00269. eCollection 2015. PMID: 26379698; PMCID: PMC4548227.
Copy Download .nbib Format: NLM
Share it on

Front Genet. 2015 Aug 25;6:269. doi: 10.3389/fgene.2015.00269. eCollection 2015.

A porcine model system of BRCA1 driven breast cancer.

Frontiers in genetics

Howard Donninger, Katharine Hobbing, M L Schmidt, Eric Walters, Laurie Rund, Larry Schook, Geoffrey J Clark

Affiliations

  1. Department of Medicine, James Graham Brown Cancer Center, University of Louisville Louisville, KY, USA.
  2. Department of Pharmacology and Toxicology, James Graham Brown Cancer Center, University of Louisville Louisville, KY, USA.
  3. Department of Biochemistry, University of Louisville Louisville, KY, USA.
  4. Division of Animal Sciences, National Swine Resource and Research Center, University of Missouri Columbia, MO, USA.
  5. Department of Animal Sciences, University of Illinois at Urbana-Champaign Urbana, IL, USA.

PMID: 26379698 PMCID: PMC4548227 DOI: 10.3389/fgene.2015.00269

Abstract

BRCA1 is a breast and ovarian tumor suppressor. Hereditary mutations in BRCA1 result in a predisposition to breast cancer, and BRCA1 expression is down-regulated in ~30% of sporadic cases. The function of BRCA1 remains poorly understood, but it appears to play an important role in DNA repair and the maintenance of genetic stability. Mouse models of BRCA1 deficiency have been developed in an attempt to understand the role of the gene in vivo. However, the subtle nature of BRCA1 function and the well-known discrepancies between human and murine breast cancer biology and genetics may limit the utility of mouse systems in defining the function of BRCA1 in cancer and validating the development of novel therapeutics for breast cancer. In contrast to mice, pig biological systems, and cancer genetics appear to more closely resemble their human counterparts. To determine if BRCA1 inactivation in pig cells promotes their transformation and may serve as a model for the human disease, we developed an immortalized porcine breast cell line and stably inactivated BRCA1 using miRNA. The cell line developed characteristics of breast cancer stem cells and exhibited a transformed phenotype. These results validate the concept of using pigs as a model to study BRCA1 defects in breast cancer and establish the first porcine breast tumor cell line.

Keywords: BRCA1; SV40 LT; breast cancer; miRNA; transformation

References

  1. Oncogene. 2007 Feb 15;26(7):1038-45 - PubMed
  2. Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9176-81 - PubMed
  3. J Cell Sci. 2007 Sep 15;120(Pt 18):3163-72 - PubMed
  4. Cancer Res. 2009 Jul 15;69(14 ):5627-9 - PubMed
  5. Breast Cancer Res. 2013 Dec 05;15(6):320 - PubMed
  6. Mol Endocrinol. 2010 Jan;24(1):76-90 - PubMed
  7. Nat Rev Mol Cell Biol. 2010 Feb;11(2):138-48 - PubMed
  8. Cancer Res. 2005 Nov 1;65(21):9824-8 - PubMed
  9. Methods. 2001 Dec;25(4):402-8 - PubMed
  10. Cancer. 2001 Jul 1;92(1):54-60 - PubMed
  11. Cancer Res. 1978 Mar;38(3):624-34 - PubMed
  12. Cloning. 1999;1(1):17-24 - PubMed
  13. FEBS J. 2015 Feb;282(4):630-46 - PubMed
  14. Cell Biosci. 2012 Feb 27;2(1):6 - PubMed
  15. Curr Biol. 2012 Sep 25;22(18):1659-66 - PubMed
  16. Histol Histopathol. 2003 Apr;18(2):541-50 - PubMed
  17. Cancer Res. 2007 Sep 1;67(17):8065-80 - PubMed
  18. Oncogene. 2005 Nov 21;24(52):7729-45 - PubMed
  19. Mol Cell Biol. 2013 May;33(9):1819-29 - PubMed
  20. Hum Mol Genet. 2001 Apr;10(7):705-13 - PubMed
  21. Biology (Basel). 2013 Jan 02;2(1):40-63 - PubMed
  22. Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1680-5 - PubMed
  23. Mol Cell. 2011 Oct 21;44(2):235-51 - PubMed
  24. Cancer Cell. 2004 Aug;6(2):171-83 - PubMed
  25. Cancer Metastasis Rev. 2013 Jun;32(1-2):25-37 - PubMed
  26. Science. 2003 Oct 24;302(5645):643-6 - PubMed
  27. Vet Pathol. 2012 Mar;49(2):344-56 - PubMed
  28. J Cell Sci. 2011 Oct 1;124(Pt 19):3189-97 - PubMed
  29. Mol Cancer Res. 2005 Oct;3(10):531-9 - PubMed
  30. Curr Stem Cell Res Ther. 2008 Dec;3(4):237-46 - PubMed
  31. Transgenic Res. 2011 Oct;20(5):975-88 - PubMed
  32. Oncology (Williston Park). 2014 Dec;28(12):1101-7, 1110 - PubMed
  33. CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36 - PubMed
  34. J Mol Med (Berl). 2003 Nov;81(11):700-7 - PubMed
  35. Trends Genet. 2001 Oct;17(10):S18-22 - PubMed

Publication Types

Grant support